Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos. Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences . Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 100
Healthy Volunteers: t
View:

• Over the age of 18

• Spanish and English-speaking people who identify as Latino

• Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment

• Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)

• Self-reports being able to read and write

• Owns a cell phone with a flat fee, and uses it at least weekly for texting.

Locations
United States
Kansas
University of Kansas Medical Center
RECRUITING
Fairway
Contact Information
Primary
Rachel Ruiz
rruiz3@kumc.edu
913-945-5052
Backup
Jaime Perales Puchalt, PhD, MPH
jperales@kumc.edu
913-588-3716
Time Frame
Start Date: 2025-02-17
Estimated Completion Date: 2029-05
Participants
Target number of participants: 288
Treatments
Experimental: CuidaTEXT
6 months of CuidaTEXT intervention + 1-month post-treatment
No_intervention: 7-Month Waitlist Control
Participants allocated to this arm will be offered the opportunity to start CuidaTEXT immediately after their 7 Month follow-up assessment
Related Therapeutic Areas
Sponsors
Collaborators: University of Puerto Rico, University of Miami, Icahn School of Medicine at Mount Sinai, National Institute on Aging (NIA)
Leads: University of Kansas Medical Center

This content was sourced from clinicaltrials.gov